In primary lung epithelial cells (“pEpi”) and established BEAS-2B epithelial cells38, ASP4132 (1 μM, 72 h) treatment failed to significantly inhibit cell viability (Fig. 1J), indicating a cancer cell specific effect by the AMPK activator. This evidence concerns the gene PRKAA1 and cancer.